My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 203

    1.

    Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes.

    Ortqvist E, Björk E, Wallensteen M, Ludvigsson J, Aman J, Johansson C, Forsander G, Lindgren F, Berglund L, Bengtsson M, Berne C, Persson B, Karlsson FA.

    Diabetes Care. 2004 Sep;27(9):2191-7.PMID: 15333483 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.

    Björk E, Berne C, Karlsson FA.

    Diabetes Care. 1998 Mar;21(3):427-30.PMID: 9540027 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.

    Björk E, Berne C, Kämpe O, Wibell L, Oskarsson P, Karlsson FA.

    Diabetes. 1996 Oct;45(10):1427-30.PMID: 8826981 [PubMed - indexed for MEDLINE]Related articles

    4.

    Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes.

    Guldstrand M, Grill V, Björklund A, Lins PE, Adamson U.

    Diabetes Metab. 2002 Dec;28(6 Pt 1):448-56.PMID: 12522324 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Insulin requirements and residual beta-cell function 12 months after concluding immunotherapy in type I diabetic patients treated with combined azathioprine and thymostimulin administration for one year.

    Moncada E, Subirá ML, Oleaga A, Goñi F, Sánchez-Ibarrola A, Monreal M, Sevilla M, Goñi MJ, Yoldi A, Terán D, et al.

    J Autoimmun. 1990 Oct;3(5):625-38.PMID: 2252531 [PubMed - indexed for MEDLINE]Related articles

    6.

    Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.

    Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, Cohen IR, Elias D.

    Diabetes Metab Res Rev. 2007 May;23(4):292-8.PMID: 17124720 [PubMed - indexed for MEDLINE]Related articles

    7.

    Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

    Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L.

    N Engl J Med. 2005 Jun 23;352(25):2598-608.PMID: 15972866 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.

    Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR.

    Lancet. 2001 Nov 24;358(9295):1749-53.PMID: 11734230 [PubMed - indexed for MEDLINE]Related articles

    9.

    Nine weeks of bedtime diazoxide is well tolerated and improves beta-cell function in subjects with Type 2 diabetes.

    Qvigstad E, Kollind M, Grill V.

    Diabet Med. 2004 Jan;21(1):73-6. Erratum in: Diabet Med. 2008 Feb;25(2):243. PMID: 14706058 [PubMed - indexed for MEDLINE]Related articles

    10.

    No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

    Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G.

    Diabetologia. 2000 Aug;43(8):1000-4.PMID: 10990077 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).

    Zhou Z, Li X, Huang G, Peng J, Yang L, Yan X, Wang J.

    Diabetes Metab Res Rev. 2005 Mar-Apr;21(2):203-8.PMID: 15386806 [PubMed - indexed for MEDLINE]Related articles

    12.

    GAD treatment and insulin secretion in recent-onset type 1 diabetes.

    Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R.

    N Engl J Med. 2008 Oct 30;359(18):1909-20. Epub 2008 Oct 8.PMID: 18843118 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Clinical manifestations and beta cell function in Swedish diabetic children have remained unchanged during the last 25 years.

    Nordwall M, Ludvigsson J.

    Diabetes Metab Res Rev. 2008 Sep;24(6):472-9.PMID: 18613248 [PubMed - indexed for MEDLINE]Related articles

    14.

    Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

    Chaillous L, Lefèvre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Maréchaud R, Bougnères P, Charbonnel B, Saï P.

    Lancet. 2000 Aug 12;356(9229):545-9.PMID: 10950231 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.

    Schloot NC, Meierhoff G, Lengyel C, Vándorfi G, Takács J, Pánczél P, Barkai L, Madácsy L, Oroszlán T, Kovács P, Sütö G, Battelino T, Hosszufalusi N, Jermendy G.

    Diabetes Metab Res Rev. 2007 May;23(4):276-85.PMID: 17103487 [PubMed - indexed for MEDLINE]Related articles

    16.

    Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial.

    Coutant R, Landais P, Rosilio M, Johnsen C, Lahlou N, Chatelain P, Carel JC, Ludvigsson J, Boitard C, Bougnères PF.

    Diabetologia. 1998 Sep;41(9):1040-6.PMID: 9754822 [PubMed - indexed for MEDLINE]Related articles

    17.

    Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study.

    Lazar L, Ofan R, Weintrob N, Avron A, Tamir M, Elias D, Phillip M, Josefsberg Z.

    Diabetes Metab Res Rev. 2007 May;23(4):286-91.PMID: 17124721 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cyclosporine in recent onset type I diabetes mellitus. Effects on islet beta cell function. Miami Cyclosporine Diabetes Study Group.

    Skyler JS, Rabinovitch A.

    J Diabetes Complications. 1992 Apr-Jun;6(2):77-88.PMID: 1611143 [PubMed - indexed for MEDLINE]Related articles

    19.

    High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

    Schnell O, Eisfelder B, Standl E, Ziegler AG.

    Diabetes. 1997 Oct;46(10):1607-11.PMID: 9313757 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.

    Ahrén B, Pacini G, Foley JE, Schweizer A.

    Diabetes Care. 2005 Aug;28(8):1936-40.PMID: 16043735 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity